Imricor Medical Systems, Inc. (ASX:IMR)

Imricor Medical Systems Statistics

Total Valuation

ASX:IMR has a market cap or net worth of AUD 481.20 million. The enterprise value is 442.25 million.

Market Cap	481.20M
Enterprise Value	442.25M

Important Dates

The next estimated earnings date is Sunday, October 26, 2025.

Earnings Date	Oct 26, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:IMR has 320.80 million shares outstanding. The number of shares has increased by 57.17% in one year.

Current Share Class	n/a
Shares Outstanding	320.80M
Shares Change (YoY)	+57.17%
Shares Change (QoQ)	+15.25%
Owned by Insiders (%)	7.44%
Owned by Institutions (%)	27.30%
Float	275.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	421.46
PB Ratio	13.67
P/TBV Ratio	13.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.06
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.10

Financial Position

The company has a current ratio of 26.23, with a Debt / Equity ratio of 1.07.

Current Ratio	26.23
Quick Ratio	25.33
Debt / Equity	1.07
Debt / EBITDA	n/a
Debt / FCF	-1.46
Interest Coverage	-1,287.95

Financial Efficiency

Return on equity (ROE) is -432.29% and return on invested capital (ROIC) is -47.54%.

Return on Equity (ROE)	-432.29%
Return on Assets (ROA)	-38.22%
Return on Invested Capital (ROIC)	-47.54%
Return on Capital Employed (ROCE)	-36.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	1.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +145.90% in the last 52 weeks. The beta is -0.09, so ASX:IMR's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+145.90%
50-Day Moving Average	1.44
200-Day Moving Average	1.46
Relative Strength Index (RSI)	51.73
Average Volume (20 Days)	287,243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:IMR had revenue of AUD 1.14 million and -54.87 million in losses. Loss per share was -0.20.

Revenue	1.14M
Gross Profit	-1.52M
Operating Income	-29.51M
Pretax Income	-54.87M
Net Income	-54.87M
EBITDA	-28.38M
EBIT	-29.51M
Loss Per Share	-0.20

Balance Sheet

The company has 76.79 million in cash and 37.84 million in debt, giving a net cash position of 38.95 million or 0.12 per share.

Cash & Cash Equivalents	76.79M
Total Debt	37.84M
Net Cash	38.95M
Net Cash Per Share	0.12
Equity (Book Value)	35.20M
Book Value Per Share	0.11
Working Capital	76.87M

Cash Flow

In the last 12 months, operating cash flow was -25.44 million and capital expenditures -420,888, giving a free cash flow of -25.86 million.

Operating Cash Flow	-25.44M
Capital Expenditures	-420,888
Free Cash Flow	-25.86M
FCF Per Share	-0.08

Margins

Gross Margin	-133.44%
Operating Margin	-2,584.69%
Pretax Margin	-4,806.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:IMR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.17%
Shareholder Yield	-57.17%
Earnings Yield	-11.40%
FCF Yield	-5.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:IMR has an Altman Z-Score of -0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.3
Piotroski F-Score	2